Prostate cancer is the second most common cancer in men. But the ratio between diagnosis and death from the disease is worth thinking about. Prostate cancer is a deadly disease so much is true with roughly 34,000 deaths in the US alone. But far from all men with that diagnosis die from prostate cancer. The problem is that the natural course of the disease is not completely understood. While some men are in danger of dying from it, others are not. Since science hasn't completely figured out how to identify those who are at risk and pick them for according treatment. This results in unnecessary diagnosis and treatment, which remain a real problem in the handling of prostate cancer. Dr. med. dr. phil. Stefan Buntrock, urologist from Göttingen, explains in this video on UroChannel the problems linked to the PSA (prostate specific antigen) test. PSA dynamics and multiparametric MRI are tools to help reduce overdetection and overtreatment. Multiparametric MRI has been around for about 15 years and is about to become standard of care soon. Overdiagnosis and overtreatment is a "must know" for every man since a simple blood test may have a profound impact upon the individual's life.

HOMEPAGE:
https://www.buntrockurologie.de/

SOCIAL MEDIA:
  / urochannel  

CHECK OUT GOLF_MD ON YOUTUBE FOR GOLF FITNESS AND MEDICAL TOPICS ON GOLF!
   / @golfmd1199  

#prostatecancer #overdiagnosis #overtreatment